Prasugrel
-
Catalog number9472-50
-
PricePlease ask
-
Size50 mg
-
-
Alternative_name2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)ethanone; CS-747, LY640315
-
DescriptionPrasugrel is novel thienopyridine antiplatelet prodrug that is metabolized to the thiol-containing active metabolite R-138727,which binds to and irreversibly inhibits the platelet P2Y12ADP receptor. Prasugrel is metabolized by the liver- and intestinal-dominant carboxylesterases CE1 and CE2 to give a mixture of four enantiomers that inhibit platelet aggregation.
-
CAS Number150322-43-3
-
Structure AvailableYes
-
Molecular FormulaC₂₀H₂₀FNO₃S
-
Molecular Weight373.44
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>5 mg/ml on warming)
-
HandlingProtect from air and light
-
Tag LineAn antiplatelet prodrug
-
Storage Condition-20°C
-
Shipping ConditionGel pack
-
Shelf Life36 months
-
MDL NumberMFCD09954140
-
PubChem CID6918456
-
SMILESCC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4
-
InChiInChI=1S/C20H20FNO3S/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21/h2-5,10,13,19H,6-9,11H2,1H3
-
InChi KeyDTGLZDAWLRGWQN-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short namePrasugrel
-
Alternative namePrasugrel
-